Division of Medical Imaging and Technology, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet and Department of Radiology, C1-46 Karolinska University Hospital, 14186, Stockholm, Sweden.
Department of Radiology, Medical Imaging Centre of Pirkanmaa Hospital District, Tampere University Hospital, Tampere, Finland.
Eur Radiol. 2017 Jan;27(1):41-50. doi: 10.1007/s00330-016-4377-4. Epub 2016 May 31.
The study aims were to evaluate: (1) whether a short-protocol (SP) MRI for the surveillance of pancreatic cystic neoplasms (PCN) provides equivalent clinical information as a comprehensive-protocol (CP), and (2) the cost reduction from substituting CP with SP for patient surveillance.
This retrospective study included 154 consecutive patients (median age: 66, 52 % men) with working-diagnosis of PCN and available contrast-enhanced MRI/MRCP. Three radiologists evaluated independently two imaging sets (SP/CP) per patient. The CP included: T2-weighted (HASTE/MRCP), DWI and T1-weighted (chemical-shift/pre-/post-contrast) images [acquisition time (AT) ≈ 35 min], whereas the SP included: T2-weighted HASTE and T1-weighted pre-contrast images (AT ≈ 8 min). Mean values of largest cyst/main pancreatic duct diameter (D/D) were compared. Agreement regarding presence/absence of cystic/MPD mural nodules (MN/MN), inter-observer agreement and cost differences between SP/CP were calculated.
For D and D, mean values with SP/CP were 21.4/21.7 mm and 3.52/3.58 mm, while mean differences SP-CP were 0.3 mm (p = 0.02) and 0.06 mm (p = 0.12), respectively. For presence/absence of MN and MN, SP/CP coincided in 93 % and 98 % of cases, respectively. Inter-observer agreement was strong for SP/CP. SP-cost was 25 % of CP-cost.
For the surveillance of PCN, short-protocol MRI provides information equivalent to the more time-consuming and costly comprehensive-protocol.
• Pancreatic cystic neoplasms (PCN) are increasingly diagnosed in the general population. • Multiple imaging controls are recommended for the surveillance of patients with PCN. • Short and comprehensive MRI-protocols are equivalent for decision-making in PCN under surveillance. • Evaluation of imaging risk factors in PCNs is comparable with both MRI-protocols. • Use of the short MRI-protocol may rationalise healthcare resources.
本研究旨在评估:(1)短方案(SP)磁共振成像(MRI)用于监测胰腺囊性肿瘤(PCN)是否可提供与综合方案(CP)相当的临床信息;(2)用 SP 替代 CP 进行患者监测所带来的成本降低。
本回顾性研究纳入了 154 例连续的 PCN 确诊患者(中位年龄:66 岁,52%为男性),并进行了增强 MRI/MRCP 检查。3 名放射科医生独立评估了每位患者的 2 组影像(SP/CP)。CP 包括:T2 加权像(HASTE/MRCP)、弥散加权成像和 T1 加权像(化学位移/对比前/后)[采集时间(AT)≈35 分钟],而 SP 则包括:T2 加权 HASTE 和 T1 加权对比前图像(AT≈8 分钟)。比较最大囊肿/主胰管直径(D/D)的平均值。计算 SP/CP 之间关于囊性/主胰管壁结节(MN/MN)存在/缺失、观察者间一致性和成本差异的结果。
SP/CP 下的 D 和 D 的平均值分别为 21.4/21.7mm 和 3.52/3.58mm,SP-CP 的平均差值分别为 0.3mm(p=0.02)和 0.06mm(p=0.12)。SP/CP 下关于 MN 和 MN 存在/缺失的结果完全一致,比例分别为 93%和 98%。SP/CP 之间观察者间一致性较强。SP 成本仅为 CP 成本的 25%。
对于 PCN 的监测,短方案 MRI 可提供与耗时更长、成本更高的综合方案相当的信息。
胰腺囊性肿瘤(PCN)在普通人群中的诊断率日益增高。
推荐对 PCN 患者进行多次影像学检查。
短方案和综合 MRI 方案在 PCN 监测中的决策制定方面等效。
两种 MRI 方案均可对 PCN 的影像学危险因素进行评估。
使用短 MRI 方案可能使医疗资源合理化。